All EDQM press releases
COVID-19 Pandemic: European Pharmacopoeia Commission session held electronically in historic first
By mid-March this year, announcements regarding the postponement or cancellation of meetings due to the COVID-19 pandemic had been made and an almost global lockdown was underway. In this unprecedented context, the European Pharmacopoeia (Ph. Eur.) Commission and its 60 groups of experts and...
Pharmacopoeial Discussion Group (PDG) videoconference meeting - April 2020
The Pharmacopoeial Discussion Group (PDG) held its interim videoconference on Thursday 12 March 2020. The PDG – which brings together the European Pharmacopoeia (Ph. Eur.), the Japanese Pharmacopoeia (JP) and the United States Pharmacopeia (USP), with WHO (International Pharmacopoeia) as...
New Council of Europe resolution will promote pharmaceutical care in Europe
A new Council of Europe resolution on the implementation of pharmaceutical care for the benefit of patients and health services has been adopted by the Committee of Ministers of the Council of Europe to improve medication use and the quality of care across Europe. The resolution defines a...
“Meet the World Pharmacopoeias” Symposium
The EDQM organised the one-day “Meet the World Pharmacopoeias” Symposium on 20 February 2020 at the EDQM premises in Strasbourg, after the 11th International Meeting of World Pharmacopoeias (IMWP), which was also hosted at its premises.
World Pharmacopoeias move towards increased global co-operation
At the 11th International Meeting of the World Pharmacopoeias (IMWP) co-hosted by the WHO and the EDQM in Strasbourg (France), national and regional pharmacopoeias brought forward initiatives to strengthen their co-operation as a way to improve public health outcomes for patients.
